I can understand being down so much however its been a ride of downs and ups, i think UPs are coming soon. Its always darkest before dawn. Well have to see how the whole NASH trial is set up Partnership, financing, CYDY has never had so much positive data now that NASh has results have been announced, yet could not capitalize on that news because of the hold looming over. Once hold is lifted opens all the possibilities of partnerships, new trails and even buyouts. Big pharmas now have the most data ever of what Leronlimab can do in NASH, Cancers, and covid/immune related conditions i think this really ups the chances of buyout combined with current rock bottom pricing. Have we ever got the updated #’s on the MTNBC cancer patients to see how cydy does vs standard of care?